Work

Trends in FDA Transporter‐Based Post‐Marketing Requirements and Commitments Over the Last Decade

Year: 2022

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.2701

Authors: Islam R. Younis, Pooja Manchandani, Hazem E. Hassan, Hisham Qosa

Institutions: Gilead Sciences (United States), Astellas Pharma (United States), University of Maryland, Baltimore, Bristol-Myers Squibb (United States)

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4283786349

FWCI: 0.523

Cites: 29

Cited by: 9

Related to: 10